Color Kinetics

Color Kinetics Announces Acquisition by Philips

Color Kinetics Announces Acquisition by Philips

June 19, 2007

Intelligent LED lighting pioneer joins global lighting leader

Mascoma Corporation

Mascoma Corporation Names James Flatt Senior Vice President of Research and Development

Mascoma Corporation Names James Flatt Senior Vice President of Research and Development

June 20, 2007

To Apply Fermentation Research and Strain Development Expertise

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mascoma Corporation, a leader in low-carbon cellulosic biomass-to-ethanol development and production, today named James H. Flatt, Ph.D. as Senior Vice President, Research and Development. In this position, Dr. Flatt will lead the company’s initiatives to develop environmentally beneficial and cost-effective technologies to convert cellulosic biomass into ethanol.

Helicos BioSciences Corporation

Helicos BioSciences Announces Commencement of Commercial Manufacturing

Helicos BioSciences Announces Commencement of Commercial Manufacturing

June 25, 2007

Industry Expert, William Cotter, Joins Helicos as Vice President of Operations

Epitome Biosystems

Epitome Biosystems Initiates Second Partnership with EMD Chemicals for Commercial Products

Epitome Biosystems Initiates Second Partnership with EMD Chemicals for Commercial Products

July 10, 2007

Waltham, MA, July 10, 2007 – Epitome Biosystems announced today a second licensing and development agreement with EMD Chemicals Inc., an affiliate of Merck KGaA of Germany, using Epitome’s EpiTag™ technology. The partnership will focus on developing EpiTag™ assays for the quantitative measurement of various targets, including membrane proteins. Products will be manufactured, marketed and sold worldwide for research applications by EMD through its well-known Novagen® brand. Sample analysis will be available as a service from Epitome.

Adnexus Therapeutics

Adnexus Therapeutics Appoints Martin Freed, MD as Chief Medical Officer

Adnexus Therapeutics Appoints Martin Freed, MD as Chief Medical Officer

July 11, 2007

Waltham, MA, July 11, 2007 – Adnexus Therapeutics today announced the expansion of its management team with the appointment of Martin I. Freed, M.D., F.A.C.P. to the newly-created role of Chief Medical Officer. Dr. Freed is an experienced drug developer in several therapeutic areas. He played a key role in the development of Avandia® (rosiglitazone maleate), a drug to treat metabolic disease, including guiding its development from a preclinical compound to the market place, and he also has experience in oncology and inflammation drug development.

Ze-gen, Inc.

Ze-gen, Inc. Secures $4.5 Million in Series A Funding from Flagship Ventures and VantagePoint Venture Partners

Ze-gen, Inc. Secures $4.5 Million in Series A Funding from Flagship Ventures and VantagePoint Venture Partners

July 16, 2007

Adds Seasoned CleanTech Investors to Board of Directors

Mascoma Corporation

Mascoma Corporation Appoints T. Jack Huggins to Board of Directors

Mascoma Corporation Appoints T. Jack Huggins to Board of Directors

July 17, 2007

Brings Expertise in Ethanol, Agribusiness, Agronomy, and Conservation

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mascoma Corporation, a leader in low-carbon cellulosic biomass-to-ethanol production through advanced biotechnology, today announced that T. Jack Huggins has joined the company’s Board of Directors.

Mascoma Corporation

Granholm Says New Ethanol Plant to Put Michigan First in Race to Turn "Wood to Wheels"

Granholm Says New Ethanol Plant to Put Michigan First in Race to Turn "Wood to Wheels"

July 19, 2007

Mascoma to invest here, partner with MSU, Michigan Tech

Ze-gen, Inc.

Ze-gen, Inc. Hosts Ribbon Cutting at Demonstration Facility in New Bedford

Ze-gen, Inc. Hosts Ribbon Cutting at Demonstration Facility in New Bedford

July 24, 2007

Facility will pilot company’s innovative waste gasification and renewable energy generation technology

LS9

Robert Walsh Appointed President of LS9, Inc., the Renewable Petroleum Company™

Robert Walsh Appointed President of LS9, Inc., the Renewable Petroleum Company™

July 30, 2007

Oil industry veteran to direct commercial development of DesignerBiofuels™ Products

SAN CARLOS, CA – July 30, 2007 – LS9, Inc., the Renewable Petroleum Company™, has named Robert Walsh its new President, effective immediately. Walsh will lead the rapid commercialization of LS9 DesignerBiofuels™ products, including a pilot facility leading to commercial production.